Brief: INVO Bioscience Regains Full U.S. Commercialization Rights
08/11/2021 21:22
Nov 8 (Reuters) - INVO Bioscience Inc INVO.O :
* INVO BIOSCIENCE REGAINS FULL U.S. COMMERCIALIZATION RIGHTS
* INVO BIOSCIENCE INC - CAN NOW FURTHER SUPPORT U.S.
FERTILITY
CLINICIANS DIRECTLY AS EXCLUSIVE PROVIDER OF INVOCELL
Source text for Eikon: ID:nPn8mN8Tga
Further company coverage: INVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on INVO Fertility
See all newsINVO Fertility Q2 revenue rises, partly on acquisitions
Invo Fertility Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Invo Fertility Inc Expected To Post A Loss Of 70 Cents A Share: Earnings Preview
Brief: INVO Fertility - Entered Into Any Market Purchase Agreement With Alumni Capital Lp
Invo Fertility Inc Reports Results For The Quarter Ended March 31: Earnings Summary